Newsroom category: BioZorb

Breast Cancer Survivors Have Sued Hologic Over Painful Complications from BioZorb Implants: Is This Device Putting Patients at Risk?

September 30, 2024

Seven breast cancer survivors have united to file a product liability lawsuit against Hologic, Inc., alleging they experienced painful complications from the BioZorb implant, a tissue marker commonly used in breast cancer treatment to help guide radiation therapy after a tumor is surgically removed. The lawsuit was filed on July 24 in U.S. District Court […]

Read More